DEA Published Updated Drugs of Abuse Report
The federal agency revised its comprehensive guide to reflect the recent rescheduling of medical marijuana.
Updated on Oct. 5, 2026 in Substance Abuse
Live Poll
Should marijuana be reclassified as a less dangerous substance under federal law?
The Drug Enforcement Administration has issued an updated Drugs of Abuse report, documenting its assessment of various substances. The new text formally acknowledges the 2026 federal rescheduling of state-licensed medical cannabis to Schedule III.
Why it matters
The revision aligns federal documentation with shifting national policy and the legal landscape following decades of state-level marijuana legalization. It serves as an official update on current federal classifications for law enforcement and health professionals.
The 119-page report confirms there have been no recorded deaths from marijuana overdose. It highlights an uptick in emergency room visits associated with the consumption of marijuana edibles.
The players
Drug Enforcement Administration
The federal law enforcement agency is responsible for combating drug trafficking and enforcing the Controlled Substances Act.
Todd Blanche
He serves as the Attorney General of the United States and oversees federal legal policy.
The details
The report cautions that cannabis usage continues to impair psychomotor behavior and learning capacity in users. It notes that this document reflects changes following Attorney General Todd Blanche moving state-licensed medical products to Schedule III in April 2026.
Timeline
The updated DEA Drugs of Abuse report was published in 2026.
Attorney General Todd Blanche moved medical marijuana to Schedule III in April 2026.
The previous version of the report was published in 2024.
The Big Picture
This publication updates the agency's guidance to reflect recent administrative changes made to the scheduling classifications within the Controlled Substances Act. It signals a formal institutional shift in how the federal government categorizes state-licensed medical products.
Patients utilizing state-licensed medical marijuana may see changes in legal and regulatory status as the federal government adopts the new Schedule III classification. The report also serves as a warning for the general public regarding the risks of increased emergency room visits from edible cannabis products.
The takeaway
The updated report provides an essential look at how federal authorities are categorizing cannabis in a changing legal environment. Consumers and patients should remain aware of reported health risks and shifts in legal status as recreational rescheduling remains under federal review.
Further reading
For more information on current federal drug classifications, visit the Substance Abuse section.
Source note: This article includes information reported by Marijuana Moment.
Live Poll
Should marijuana be reclassified as a less dangerous substance under federal law?
